Expression of mRNA for growth hormone-releasing hormone and splice variants of GHRH receptors in human malignant bone tumors

Regulatory Peptides

Volumn 108, Issue 2-3, 2002, Pages 47-53

  Busto, R ^a,b   Schally, A V ^a,b   Braczkowski, R ^a,b   Plonowski, A ^a,b   Krupa, M ^a,b   Groot, K ^a   Armatis, P ^a   Varga, J L ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anticancer drugs; Autocrine growth factors; GHRH; GHRH antagonists; GHRH receptors; Human malignant bone tumors

Indexed keywords

GROWTH HORMONE RELEASING FACTOR; GROWTH HORMONE RELEASING FACTOR RECEPTOR; GROWTH HORMONE RELEASING HORMONE ANTAGONIST; GROWTH HORMONE RELEASING HORMONE ANTIBODY; HORMONE RELEASE INHIBITING FACTOR; JV 138; MESSENGER RNA; PEPTIDE HORMONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOCRINE EFFECT; BONE TUMOR; CELL CULTURE; CELL GROWTH; CELL LINE; CELL PROLIFERATION; CELL SECRETION; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MALE; MOUSE; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA TRANSLATION; TUMOR CELL;

ALTERNATIVE SPLICING; ANIMALS; BASE SEQUENCE; BONE NEOPLASMS; DNA PRIMERS; GONADOTROPIN-RELEASING HORMONE; HUMANS; MALE; MICE; MICE, NUDE; OSTEOSARCOMA; RECEPTORS, LHRH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SARCOMA; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; VARIATION (GENETICS);

MUS MUSCULUS;

EID: 0037107433     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(02)00109-X     Document Type: Article

References (35)

1. Pinski J., Schally A.V., Groot K., Halmos G., Szepeshazi K., Zarandi M.et al. Inhibition of growth of human osteosarcomas by antagonists of growth hormone-releasing hormone. J. Natl. Cancer Inst. 87:1995;1787-1794.
2. Braczkowski R., Schally A.V., Plonowski A., Varga J.L., Groot K., Krupa M. Inhibition of proliferation of human MNNG/HOS Osteoshrcomas and SK-ES-1 Ewing's sarcom cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects of 16 F-II. Cancer. 2002;. in print.
3. Schally A.V., Comaru-Schally A.M., Nagy A., Kovacs M., Szepeshazi K., Plonowski A.et al. Hypothalamic hormones and cancer. Front. Neuroendocrinol. 22:2001;248-291.
4. Rosen G. Bone tumors. 3rd ed. Holland J.K., Frei E. III, Bast R.C. Jr., Kufe D.E., Morton D.L., Weichselbaum R.R. Cancer Medicine. vol. 2:1993;1825-1884 Lea & Febiger, Philadelphia.
5. Khandwala H.M., McCutcheon I.E., Flyvbjerg A., Freind K.E. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr. Rev. 21:2000;215-244.
6. Togari A., Arai M., Mizutani S., Mizutani S., Koshihara Y., Nagatsu T. Expression of mRNAs for neuropeptide receptors and β-adrenergic receptors in human osteoblasts and human sarcoma cells. Neurosci. Lett. 233:1997;125-128.
7. Benini S., Baldini N., Manara M.C., Chano T., Serra M., Rizzi S.et al. Redundancy of autocrine loops in human osteosarcoma cells. Int. J. Cancer. 80:1999;581-588.
8. Gaylinn B.D., Harrison J.K., Zysk J.R., Lyons C.E., Lynch K.R., Thorner M.O. Molecular cloning and expression of human anterior pituitary receptor for growth hormone-releasing hormone. Mol. Endocrinol. 7:1993;77-84.
9. Schally A.V., Varga J.L. Antagonistic analogs of growth hormone-releasing hormone (GHRH): new potential antitumor agents. Trends Endocrinol. Metab. 10:1999;383-391.
10. Kiaris H., Schally A.V., Varga J.L. Antagonists of growth hormone-releasing hormone inhibit the growth of U-87MG human glioblastoma in nude mice. Neoplasia. 2:2000;242-250.
11. Pinski J., Schally A.V., Jungwirth A., Groot K., Halmos G., Armatis P.et al. Inhibition of growth of human small cell and nonsmall cell lung carcinomas by antagonists of growth hormone-releasing hormone (GHRH). Int. J. Oncol. 9:1996;1099-1105.
12. Kiaris H., Schally A.V., Varga J.L., Groot K., Armatis P. Growth hormone-releasing hormone: an autocrine growth factor for small cell lung carcinoma. Proc. Natl. Acad. Sci. U. S. A. 96:1999;14894-14898.
13. Jungwirth A., Schally A.V., Pinski J., Halmos G., Groot K., Armatis P.et al. Inhibition of in vivo proliferation of androgen-independent prostate cancers by an antagonist of growth hormone-releasing hormone. Br. J. Cancer. 75:1997;1585-1592.
14. Lamharzi N., Schally A.V., Koppan M., Groot K. Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of Insulin Like Growth Factor II in tumors. Proc. Natl. Acad. Sci. U. S. A. 95:1998;8864-8868.
15. Jungwirth A., Schally A.V., Pinski J., Groot K., Armatis A. Growth hormone-releasing hormone (GHRH) antagonist MZ-4-71 inhibits in vivo proliferation of Caki-I renal adenocarcinoma. Proc. Natl. Acad. Sci. U. S. A. 94:1997;5810-5813.
16. Halmos G., Schally A.V., Varga J.L., Plonowski A., Rekasi Z., Czompoly T. Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone. Proc. Natl. Acad. Sci. U. S. A. 97:2000;10555-10560.
17. Szepeshazi K., Schally A.V., Groot K., Armatis P., Hebert F., Halmos G. Antagonists of growth hormone releasing hormone (GHRH) inhibit in vivo proliferation of experimental pancreatic cancers and decrease IGF-II levels in tumors. Eur. J. Cancer. 36:2000;128-136.
18. Szepeshazi K., Schally A.V., Groot K., Armatis P., Halmos G., Hebert F.et al. Antagonists of growth hormone-releasing hormone (GHRH) inhibit IGF-II production and growth of HT-29 human colon cancers. Br. J. Cancer. 82:2000;1724-1731.
19. Kahan Z., Varga J.L., Schally A.V., Rekasi Z., Armatis P., Chatzistamou I.et al. Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice. Breast Cancer Res. Treat. 60:2000;71-79.
20. Chatzistamou I., Schally A.V., Varga J.L., Groot K., Busto R., Armatis P.et al. Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormone. Anti-Cancer Drugs. 12:2001;761-768.
21. Chatzistamou I., Schally A.V., Varga J.L., Groot K., Armatis P., Busto R.et al. Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of OV-1063 human epithelial ovarian cancer cell line xenografted into nude mice. J. Clin. Endocrinol. Metab. 86:2001;2144-2152.
22. Csernus V.J., Schally A.V., Kiaris H., Armatis P. Inhibition of growth, production of insulin-like growth factor-II (IGF-II), and expression of IGF-II mRNA of human cancer cell lines by antagonistic analogs of growth hormone-releasing hormone in vitro. Proc. Natl. Acad. Sci. U. S. A. 96:1999;3098-3103.
23. Matsubara S., Sato M., Mizobuchi M., Niimi M., Takahara J. Differential gene expression of growth hormone (GH) -releasing hormone (GHR) and GHR receptors in various rat tissues. Endocrinology. 136:1995;4147-4150.
24. Khorram O., Garthwaiter M., Grosen E., Golos T. Human uterine and ovarian expression of growth hormone-releasing hormone messenger RNA in benign and malignant gynecologic conditions. Fertil. Steril. 75:2001;174-179.
25. Rekasi Z., Czompoly T., Schally A.V., Halmos G. Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors for human cancers. Proc. Natl. Acad. Sci. U. S. A. 97:2000;10561-10566.
26. Frohman L.A., Szabo M. Ectopic production of growth hormone-releasing factor by carcinoid and pancreatic islet tumors associated with acromegaly. Prog. Clin. Biol. Res. 74:1981;259-271.
27. Kahan Z., Arencibia J., Csernus V., Groot K., Kineman R., Robinson W.R.et al. Expression of growth hormone-releasing hormone (GHRH) messenger ribonucleic acid and the presence of biologically active GHRH in human breast, endometrial, and ovarian cancers. J. Clin. Endocrinol. Metab. 84:1999;582-589.
28. Plonowski A., Schally A.V., Busto R., Krupa M., Varga J.L., Halmos G. Expression of growth hormone-releasing hormone (GHRH) and splice variants of GHRH receptors in human experimental prostate cancers. Peptides. 23:2002;1127-1133.
29. Kiaris H., Schally A.V., Busto R., Halmos G., Artavanis-Tsakonas S., Varga J.L. Expression of a splice variant of the receptor for growth hormone-releasing hormone (GHRH) in 3T3 fibroblasts activates cell proliferation responses to GHRH analogs. Proc. Natl. Acad. Sci. 99:2002;196-200.
30. Varga J.L., Schally A.V., Csernus V., Zarandi M., Halmos G., Groot K.et al. Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities. Proc. Natl. Acad. Sci. U. S. A. 96:1999;692-697.
31. Groot K., Csernus V.J., Pinski J., Zsigo J., Rekasi Z., Zarandi M.et al. Development of a radioimmunoassay for some agonists of growth hormone-releasing hormone. Int. J. Pept. Protein Res. 41:1993;162-168.
32. Losa M., Wolfram G., Mojto J., Schopohl J., Spiess Y., Huber R.et al. Presence of growth hormone-releasing hormone-like immunoreactivity in human tumors: characterization of immunological and biological properties. J. Clin. Endocrinol. Metab. 70:1990;62-68.
33. Gaylinn B.D. Molecular and cell biology of the growth hormone-releasing hormone receptor. Growth Horm. IGF Res. 9:1999;37-44.
34. Rekasi Z., Varga J.L., Schally A.V., Halmos G., Armatis P., Groot K.et al. Antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide inhibit tumor proliferation by different mechanisms: evidence from in vitro studies on human prostatic and pancreatic cancers. Endocrinology. 141:2000;2120-2128.
35. Kiaris H., Schally A.V., Varga J.L. Suppression of tumor growth by growth hormone-releasing hormone antagonist JV-1-36 does not involve the inhibition of autocrine production of insulin-like growth factor II in H-69 small cell lung carcinoma. Cancer Lett. 161:2000;149-155.